Correlation of the mutation of p53 gene and the polymorphism at codon 72 in smoking-related non-small cell lung cancer patients

International Journal of Oncology

Volumn 12, Issue 3, 1998, Pages 577-581

  Murata, Motoi ^a   Tagawa, Masatoshi ^a   Kimura, Hideki ^a   Kakisawa, Kimitaka ^b   Shirasawa, Hiroshi ^c   Fujisawa, Takehiko ^b  

^a CHIBA CANCER CENTER   (Japan)

^b Chiba University   (Japan)

^c Department of Microbiology ^*  (Japan)

Author keywords

Non small cell lung cancer; p53 mutation; p53 polymorphism

Indexed keywords

ARGININE; PROLINE; PROTEIN P53;

ADULT; AGED; ALLELE; ARTICLE; CONTROLLED STUDY; DNA POLYMORPHISM; FEMALE; GENE MUTATION; GENOTYPE; HUMAN; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; MUTATION RATE; ONSET AGE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN POLYMORPHISM; SINGLE STRAND CONFORMATION POLYMORPHISM; SMOKING; TUMOR SUPPRESSOR GENE;

EID: 0031883888     PISSN: 10196439     EISSN: None     Source Type: Journal    
DOI: 10.3892/ijo.12.3.577     Document Type: Article

References (19)

1. Greenblatt MS, Bennett WP, Hollstein M and Harris CC: Mutations in p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis. Cancer Res 54: 4855-4878, 1994.
2. Harris CC: p53 tumor suppressor gene: from the basic research laboratory to the clinic - an abridged historical perspective. Carcino-genesis 17: 1187-1198, 1996.
3. De Fromentel CC and Soussi T: TP53 tumor suppressor gene: a model for investigating human mutagenesis. Genes Chromosomes Cancer 4: 1-15, 1992.
4. Suzuki H, Takahashi T, Kuroishi T, Suyama M, Ariyoshi Y, Takahashi T and Ueda R: p53 mutations in non-small cell lung cancer in Japan: association between mutations and smoking. Cancer Res 52: 734-736, 1992.
5. Kishimoto Y, Murakami Y, Shiraishi M, Hayashi K and Sekiya T: Aberrations of the p53 tumor suppressor gene in human nonsmall cell carcinoma of the lung. Cancer Res 52: 4799-4804, 1992.
6. Westra WH, Offerhaus GJA, Goodman SN, Slebos RJC, Polak M, Baas IO, Rodenhuis S and Hruban RH: Overexpression of the p53 tumor suppressor gene product in primary lung adenocarcinomas is associated with cigarette smoking. Am J Surg Pathol 17: 213-220, 1993.
7. Dosaka-Akita H, Shindoh M, Fujino M, Kinoshita I, Akie K, Katoh M and Kawakami Y: Abnormal p53 expression in human lung cancer is associated with histologic subtypes and patient smoking history. Am J Clin Pathol 102: 660-664, 1994.
8. Kashii T, Mizushima Y, Lima CEQ, Noto H, Sato H, Kusajima Y, Kitagawa M, Yamamoto K and Kobayashi M: Studies on clinico-pathological features of lung cancer patients with K-ras/p53 gene alterations: comparison between younger and older groups. Oncology 52: 219-225, 1995.
9. Wang X, Christiani DC, Wiencke JK, Fischbein M, Xu X, Cheng TJ, Mark E, Wain JC and Kelsey KT: Mutations in the p53 gene in lung cancer are associated with cigarette smoking and asbestos exposure. Cancer Epidemiol Biomarkers Prev 4: 543-548, 1995.
10. Kondo K, Tsuzuki H, Sasa M, Sumitomo M, Uyama T and Monden Y: A dose-response relationship between the frequency of p53 mutations and tobacco consumption in lung cancer patients. J Surg Oncol 61: 20-26, 1996.
11. Matlashewski GJ, Tuck S, Pim D, Lamb P, Schneider J and Crawford LV: Primary structure polymorphism at amino acid residue 72 of human p53. Mol Cell Biol 7: 961-963, 1987.
12. Wu WJ, Kakehi Y, Habuchi T, Kinoshita H, Ogawa O, Terachi T, Huang CH, Chiang CP and Yoshida O: Allelic frequency of p53 gene codon 72 polymorphism in urologic cancers. Jpn J Cancer Res 86: 730-736, 1995.
13. Weston A, Perrin LS, Forrester K, Hoover RN, Trump BF, Harris CC and Caporaso NE: Allelic frequency of p53 polymorphism in human lung cancer. Cancer Epidemiol Biomarkers Prev 1: 481-483, 1992.
14. Kawajiri K, Nakachi K, Imai K, Watanabe J and Hayashi S: Germ line polymorphisms of p53 and CYP1A1 genes involved in human lung cancer. Carcinogenesis 14: 1085-1089, 1993.
15. Birgander R, Sjalander A, Rannung A, Alexandrie AK, Sandberg MI, Seidegard J, Tornling G, Beckman G and Beckman L: p53 polymorphisms and haplotypes in lung cancer. Carcinogenesis 16: 2233-2236, 1995.
16. Jin X, Wu X, Roh JA, Amos CI, King TM, Branch C, Honn SE and Spizt MR: Higher lung cancer risk for younger African-Americans with Pro/Pro p53 genotype. Carcinogenesis 16: 2205-2208, 1995.
17. Murata M, Tagawa M, Kimura M, Kimura H, Watanabe S and Saisho H: Analysis of a germ line polymorphism of the p53 gene in lung cancer patients; discrete results with smoking history. Carcinogenesis 17: 261-264, 1996.
18. Murakami Y, Hayashi K and Sekiya T: Detection of aberrations of the p53 alleles and the gene transcript in human tumor cell lines by single-strand conformation polymorphism analysis. Cancer Res 51: 3356-3361, 1991.
19. Snedecor GW and Cochran WG: Statistical Methods. The Iowa State University Press, Ames, Iowa, 1967.